Oxitec Launches Sparks™, a Commercial Platform to Scale Dengue-Blocking Wolbachia Solution, Aiming to Rapidly Increase Supply, Drive Down Costs, and Protect One Billion People by 2040
Sparking Joy by Eliminating Dengue
Sparks™ is a new initiative to scale Wolbachia Replacement Technology (WRT), a proven, non-GMO approach to block dengue transmission, using the strength of Oxitec’s platform and global partnerships.
Leveraging two decades of expertise and leadership developing and scaling biological solutions to address disease-spreading vectors and agricultural pests, and supported by a significant investment from the Gates Foundation, Sparks™ will rapidly scale WRT supply and pursue access-enhancing pricing for communities most in need as set forth by World Health Organization (WHO) guidelines.